Early Deaths in Pediatric Acute Leukemia: A Major Challenge in Developing Countries

Area of Science:

• Pediatric Oncology
• Hematology
• Clinical Research

Background:

• Treatment-related mortality is a significant concern in pediatric acute leukemia, particularly during the induction phase.
• Early deaths in children with acute leukemia are frequently linked to complications like infections and cerebrovascular events.

Purpose of the Study:

• To determine the incidence and risk factors associated with increased mortality during induction therapy for pediatric acute leukemia.
• To evaluate the impact of enhanced supportive care measures on mortality rates in this patient population.

Main Methods:

• A retrospective study was conducted involving 370 pediatric acute leukemia patients treated at the National Cancer Institute, Cairo University, from January 2011 to December 2013.
• Patient data included diagnoses of acute lymphoblastic leukemia, acute myeloid leukemia, and mixed phenotype acute leukemia.
• Mortality rates were analyzed, comparing outcomes before and after the implementation of enhanced supportive care measures in 2013.

Main Results:

• The overall and induction mortality rates were 40.5% and 19.2%, respectively.
• Infections accounted for the majority of early deaths (64.7%), followed by cerebrovascular accidents (18.3%).
• Implementation of enhanced supportive care in 2013 led to a significant reduction in overall mortality (29%) and induction mortality (13.6%) compared to 2011 (46% and 20.3%).

Conclusions:

• Induction deaths in pediatric acute leukemia present a substantial challenge, especially in developing nations.
• Enhanced supportive care measures are crucial and effective in improving survival outcomes for children undergoing acute leukemia induction therapy.